NGM · Drug Manufacturers - Specialty & Generic

AQST (AQST) Stock

$3.60 -4.26% NGM: AQST Healthcare

Valuation

MetricValue
Price$3.60
Market Cap$451.68M
P/E Ratio-6.11
P/B Ratio-13.43
P/S Ratio9.31
EPS (TTM)$-0.76
52-Week High$7.55
52-Week Low$2.93
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE190.87%
ROA-48.83%
ROCE-51.10%
Gross Margin-153.33%
Operating Margin-155.56%
Net Margin-137.08%
Debt/Equity-3.92
Current Ratio3.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$51.0M$48.0M$51.0M$58.0M$45.0M
Operating Profit$-35.0M$-42.0M$-15.0M$-31.0M$-70.0M
Net Profit$-71.0M$-54.0M$-8.0M$-44.0M$-84.0M
EPS$-1.85$-1.12$-0.13$-0.51$-0.76
Op Margin-68.2%-88.2%-29.9%-53.5%-156.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$62.0M$57.0M$57.0M$101.0M$160.0M
Total Liabilities$144.0M$176.0M$164.0M$162.0M$194.0M
Cash$28.0M$27.0M$24.0M$72.0M$121.0M
Borrowings$56.0M$57.0M$33.0M$38.0M$131.0M

Latest News

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism GlobeNewswire · Jul 7, 2026 Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last? Zacks · Jun 24, 2026 Does US manufacturing give drugmakers a speed edge? Pharma Voice · Jun 23, 2026 The Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Are Out And Analysts Have Published New Forecasts Simply Wall St. · May 15, 2026 Aquestive Therapeutics Inc (AQST) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... GuruFocus.com · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-33.0M$-10.0M$-6.0M$-36.0M$-52.0M
Investing Cash Flow$-2.0M$-5.0M$-2.0M$0$-1.0M
Financing Cash Flow$0$0$15.0M$0$-1.0M
Net Cash Flow$-4.0M$-1.0M$-3.0M$48.0M$50.0M
Free Cash Flow$-34.0M$-12.0M$-7.0M$-36.0M$-53.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.51
EV / EBITDA-9.51
FCF Yield-11.73%
Quick Ratio2.98
Interest Coverage-4.12
Return 1Y-11.50%
Return 3Y143.23%
Return 5Y18.98%

Ownership

Insiders Held3.10%
Institutions Held58.83%
Institutions Float Held60.71%
Institutional HolderSharesReport Date
Bratton Capital Management, LP9,810,9582026-03-31
Blackrock Inc.7,509,0712026-03-31
RTW Investments LP7,426,4712026-03-31
Vanguard Capital Management LLC4,443,6982026-03-31
Federated Hermes, Inc.2,940,3392026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARVN $8.02 -3.43% -6.94 $517.14M 0.00%
AVXL $2.49 -3.11% -5.02 $230.75M 0.00%
DRIO $7.47 -4.11% -10.51 $54.62M 0.00%
EBS $7.16 -1.45% 8.67 $369.17M 0.00%
ERAS $17.72 -2.42% -23.45 $6.15B 0.00%

About AQST

AQST is led by CEO Daniel Barber, employs 142 people, headquartered in US, publicly traded since 2018.

AQST stock trades at $3.60 with a market capitalization of $451.68M. The stock is valued at a price-to-earnings (P/E) ratio of -6.11, price-to-book of -13.43, price-to-sales of 9.31. Over the past 52 weeks the stock has ranged between $2.93 and $7.55, and currently trades 52.3% below its 52-week high.

On profitability, AQST generates a return on equity (ROE) of 190.87% — well above the market average, a sign of a high-quality business, return on capital employed of -51.10%, an operating margin of -155.56%, a net profit margin of -137.08%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides